The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
CorrectionFull Access

Correction

The article “Inhibition of Norepinephrine Uptake in Patients With Major Depression Treated With Paroxetine” by Michelle L. Gilmor, Ph.D., et al. (October 2002; 159:1702–1710) contains two errors. In the first sentence of the Method section of the abstract (p. 1702), the dose range for desipramine should read: “to 300 mg/day.” In the Clinical Data—Paroxetine subsection of the Results section (p. 1705), the third sentence in the second paragraph should read: “At a serum concentration of 200 ng/ml, norepinephrine and 5-HT uptake were 57% and 10% of control, respectively.”